Registered Executive Kim Su-chan Acquires 668 Shares via Employee Stock Plan, Ownership Remains Negligible at 0.00%

Pharmicell registered executive Kim Su-chan acquired an additional 668 common shares through the employee stock ownership plan as of the report base date of June 19, 2026.
This transaction increases his total holdings from 3,746 to 4,414 shares, but his ownership ratio remains 0.00% of the total outstanding shares of 60,004,014, representing negligible change.
The acquisition is a minor adjustment from employee share vesting with no capital raising, convertible issuance, or strategic shift involved, thus having no material impact on stock price or shareholder value.
[AI Summary]The executive's minor share acquisition via employee stock plan represents only 0.00% of outstanding shares, causing negligible dilution or impact on existing shareholders, and is a routine disclosure without capital allocation or governance changes.